New patent expiration for Gilead Sciences drug ODEFSEY
Annual Drug Patent Expirations for ODEFSEY Odefsey is a drug marketed by Gilead Sciences Inc and is included in one […]
New patent expiration for Gilead Sciences drug ODEFSEY Read Post »
Annual Drug Patent Expirations for ODEFSEY Odefsey is a drug marketed by Gilead Sciences Inc and is included in one […]
New patent expiration for Gilead Sciences drug ODEFSEY Read Post »
Annual Drug Patent Expirations for CABENUVA+KIT Cabenuva Kit is a drug marketed by Viiv Hlthcare and is included in one
New patent expiration for Viiv Hlthcare drug CABENUVA KIT Read Post »
Annual Drug Patent Expirations for COMPLERA Complera is a drug marketed by Gilead Sciences Inc and is included in one
New patent expiration for Gilead Sciences drug COMPLERA Read Post »
Annual Drug Patent Expirations for EDURANT Edurant is a drug marketed by Janssen Prods and is included in one NDA.
New patent expiration for Janssen Prods drug EDURANT Read Post »
Annual Drug Patent Expirations for JULUCA Juluca is a drug marketed by Viiv Hlthcare and is included in one NDA.
New patent expiration for Viiv Hlthcare drug JULUCA Read Post »
Annual Drug Patent Expirations for REVLIMID Revlimid is a drug marketed by Celgene and is included in one NDA. It
Annual Drug Patent Expirations for BYDUREON Bydureon is a drug marketed by Astrazeneca Ab and is included in two NDAs.
New patent expiration for Astrazeneca Ab drug BYDUREON Read Post »
Annual Drug Patent Expirations for BYDUREON+PEN Bydureon Pen is a drug marketed by Astrazeneca Ab and is included in one
New patent expiration for Astrazeneca Ab drug BYDUREON PEN Read Post »
Annual Drug Patent Expirations for BYDUREON+BCISE Bydureon Bcise is a drug marketed by Astrazeneca Ab and is included in one
New patent expiration for Astrazeneca Ab drug BYDUREON BCISE Read Post »
Get fresh news and insights, drug patent expirations & more…